Share Twitter LinkedIn Facebook Email Scott Fields, SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Treatment With Xofigo, Abiraterone, & Copanlisib. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
